DORIO, ANNALISA SUSANNA
 Distribuzione geografica
Continente #
NA - Nord America 5.339
EU - Europa 1.116
AS - Asia 101
SA - Sud America 5
AF - Africa 1
OC - Oceania 1
Totale 6.563
Nazione #
US - Stati Uniti d'America 5.335
IT - Italia 591
DE - Germania 167
FR - Francia 86
UA - Ucraina 85
CN - Cina 65
IE - Irlanda 49
PL - Polonia 32
SE - Svezia 32
GB - Regno Unito 30
FI - Finlandia 18
KR - Corea 15
RU - Federazione Russa 13
VN - Vietnam 6
IN - India 5
CH - Svizzera 4
CA - Canada 3
IR - Iran 3
JP - Giappone 3
AL - Albania 2
AR - Argentina 2
BR - Brasile 2
HR - Croazia 2
AU - Australia 1
BD - Bangladesh 1
BE - Belgio 1
ES - Italia 1
GR - Grecia 1
KZ - Kazakistan 1
MA - Marocco 1
MX - Messico 1
NL - Olanda 1
RO - Romania 1
TR - Turchia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 6.563
Città #
Woodbridge 1.768
Houston 1.380
Wilmington 1.130
Ann Arbor 164
Chandler 157
Fairfield 140
Ashburn 85
Jacksonville 71
Rome 55
Seattle 54
Dublin 45
New York 43
Cambridge 41
Milan 39
Medford 35
Kraków 30
Beijing 29
Dearborn 18
Lawrence 17
Palo Alto 14
Naples 13
Mülheim 12
Florence 10
Napoli 10
Menlo Park 8
Verona 8
Zhengzhou 8
Catania 7
Mountain View 7
Paris 7
Benevento 6
Dong Ket 6
Hefei 6
Renton 6
San Diego 6
Senigallia 6
Bari 5
Berlin 5
Boardman 5
Bologna 5
Frankfurt (Oder) 5
Guangzhou 5
Modugno 5
Palermo 5
Perugia 5
Cagliari 4
Civitavecchia 4
Falls Church 4
Indiana 4
Nanjing 4
Turin 4
University Park 4
Ardea 3
Baronissi 3
Brescia 3
Catanzaro 3
Genoa 3
Giugliano in Campania 3
Hounslow 3
Lausanne 3
London 3
Nürnberg 3
Padova 3
Phoenix 3
Saint Petersburg 3
San Mateo 3
Shanghai 3
Udine 3
Arosio 2
Athens 2
Carugate 2
Casamassima 2
Chiari 2
Dalmine 2
Duncan 2
Erice 2
Jinan 2
Kunming 2
Lecce 2
Magenta 2
Mercato San Severino 2
Modena 2
Nardò 2
Nocera Inferiore 2
Orzinuovi 2
Pescara 2
Pignola 2
Pune 2
Redmond 2
Redwood City 2
San Chirico Raparo 2
San Francisco 2
Sanremo 2
Santa Maria Capua Vetere 2
Scottsdale 2
Siena 2
Sorrento 2
Spezzano Della Sila 2
Torino 2
Toronto 2
Totale 5.626
Nome #
Silenziamento vs inibizione farmacologica della poli (adp-ribosio) polimerasi-1 (parp-1): differenti effetti sulla chemio-sensibilità tumorale, in vivo ed in vitro 718
Common fragile sites in colon cancer cell lines: role of mismatch repair, RAD51 and poly(ADP-ribose) polymerase-1 435
Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity 428
The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanoma 421
Poly(ADP-ribose) polymerase signaling of topoisomerase 1-dependent DNA damage in carcinoma cells 418
Novel Glutathione S-Transferase Inhibitor Enhances Temozolomide Efficacy Against Malignant Melanoma 52nd Annual Meeting of the Italian Cancer Society. Lost in translation: bridging the gap between cancer research and effective therapies 384
Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis 381
Pharmacological inhibition of poly(ADP-ribose) polymerase activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells 372
The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma 363
Pharmacological inhibition of poly (ADP-ribose) polymerase (PARP) activity down-regulates the expression of syndecan-4 and Id-1 in endothelial cells and increases temozolomide sensitivity of PARP-1 silenced melanoma cells. 357
Pharmacological Inhibition of Poly(ADP-ribose) Polymerase (PARP) Activity in PARP-1 Silenced Tumour Cells Increases Chemosensitivity to Temozolomide and to a N3-Adenine Selective Methylating Agent. 355
Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding 343
Activity against melanoma of an anti-vascular endothelial growth factor receptor-1 (VEGFR-1) monoclonal antibody that does not hamper ligand binding 340
Targeting angiogenesis with poly(ADP-ribose) polymerase inhibitors 331
Inhibition of poly(ADP-ribose) polymerase prevents irinotecan-induced intestinal damage and enhances irinotecan/temozolomide efficacy against colon carcinoma. 324
Inhibition of endothelial cell migration and angiogenesis by a vascular endothelial growth factor receptor-1 derived peptide 319
Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity to temozolomide. 17th International Symposium on poly(ADP-ribosyl)ation. 312
Totale 6.601
Categoria #
all - tutte 11.019
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.019


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019506 0 0 0 0 0 0 0 0 0 148 183 175
2019/20201.553 163 118 112 153 144 156 131 149 133 113 98 83
2020/2021796 90 86 73 94 85 93 87 85 29 18 36 20
2021/2022240 6 23 16 5 9 22 15 14 22 37 11 60
2022/2023496 39 47 28 71 35 80 40 30 57 13 30 26
2023/2024230 44 13 16 12 29 59 27 17 7 6 0 0
Totale 6.601